查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1555638

经导管主动脉瓣置换市场：2024-2031年全球产业分析、规模、占有率、成长、趋势、预测

Transcatheter Aortic Valve Replacement Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 175 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球经导管主动脉瓣置换术（TAVR）市场的综合报告，深入分析了主要市场动态，包括驱动因素、机会、挑战和趋势。本报告提供了有关市场结构和未来前景的宝贵见解。

主要见解

  • 经导管主动脉瓣置换术市场规模（2024年）：56.4亿美元
  • 预测市值（2031年）：105亿美元
  • 全球市场成长率（2024-2031年年复合成长率）：6.5%

经导管主动脉瓣置换市场-调查范围：

TAVR 市场致力于基于经导管的手术，用于更换受损的主动脉瓣，特别是对于传统心臟直视手术处于高或中风险的患者。由于阀门技术和微创技术的进步，该市场迅速扩大。由于人口老化和心血管疾病盛行率上升，世界各地的医院、心臟中心和诊所日益采用 TAVR 手术。

市场驱动因素：

全球 TAVR 市场主要是由 TAVR 手术适应症的扩大所推动的，特别是对于低风险患者。灵活、先进的输送系统的发展使移植手术变得更加顺利和安全。阀门材料的持续技术创新和阀门耐用性的提高进一步推动市场成长。此外，人口老化的加剧和主动脉瓣狭窄的高盛行率导致对 TAVR 手术的需求不断成长。

市场限制因素：

儘管 TAVR 市场呈现出良好的成长形势，但仍有一些挑战阻碍其充分发挥潜力。 TAVR 设备和手术的高成本，加上复杂的监管环境，尤其是在新兴市场，是主要障碍。此外，某些地区缺乏熟练的专业人员来执行这些高度专业化的程序，限制了更广泛的市场采用。对低风险患者瓣膜长期耐用性的担忧也为市场扩张带来了挑战。

市场机会：

TAVR 市场提供了巨大的成长机会，特别是在医疗保健现代化不断发展的新兴市场。在亚太地区等地区，医疗保健成本的上升和先进治疗方法的改善为市场进入者创造有利的机会。此外，老年族群对微创治疗意识的增强以及对非手术选择的日益偏好推动对 TAVR 手术的需求。

本报告涵盖的主要问题

  • 推动全球 TAVR 市场的主要因素是什么？
  • 市场在不同医疗保健环境中的扩张情况如何？
  • 哪些技术创新塑造 TAVR 手术的未来？
  • 采用什么策略来维持市场竞争力？
  • 全球 TAVR 市场有哪些新趋势？

目录

第1章 执行摘要

第2章 市场概述

  • 市场范围与定义
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 课题
    • 主要趋势
  • 经导管主动脉瓣置换术采用/使用分析：依地区
  • PESTLE分析
  • 各地区的主要法规
  • 波特五力分析
  • 宏观经济因素
    • 世界产业展望
    • 世界 GDP 成长前景
    • 世界母市场概览

第3章 2019-2023年价格趋势分析

  • 主要亮点
  • 影响治疗费用的主要因素
  • 依治疗收费
  • 区域定价和说明

第4章 全球经导管主动脉瓣置换市场展望：过去（2019-2023年）与预测（2024-2031年）

  • 主要亮点
    • 市场价值（十亿美元）预测
    • 市场规模及年成长率
    • 绝对的获利机会
  • 市场规模分析与预测（十亿美元）
    • 过去的市场规模分析，2019-2023年
    • 目前市场规模预测，2023-2031年
  • 全球经导管主动脉瓣置换市场展望：程序
    • 简介/主要调查结果
    • 2019-2023年市场规模（价值与数量）分析
    • 2024-2031年市场规模（价值与数量）预测
      • 经股骨植入物
      • 经心尖植体
      • 经主动脉植入物
  • 市场吸引力分析：技术
  • 全球经导管主动脉瓣置换市场展望：机制
    • 简介/主要调查结果
    • 2019-2023年市场规模（金额）分析
    • 2024-2031年市场规模（金额）预测
      • 自我扩张
      • 气球可膨胀
  • 市场吸引力分析：机制
  • 全球经导管主动脉瓣置换市场展望：最终应用
    • 简介/主要调查结果
    • 2019-2023年市场规模（金额）分析
    • 2024-2031年市场规模（金额）预测
      • 医院
      • 门诊手术中心
      • 其他
  • 市场吸引力分析：最终用途

第5章 全球经导管主动脉瓣置换市场展望：地区

  • 主要亮点
  • 2019-2023年市场规模（金额）分析
  • 2024-2031年市场规模（金额）预测
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东、非洲
  • 市场吸引力分析：地区

第6章 北美经导管主动脉瓣置换市场展望：过去（2019-2023年）与预测（2024-2031年）

第7章 欧洲经导管主动脉瓣置换市场展望：过去（2019-2023年）与预测（2024-2031年）

第8章 亚太地区经导管主动脉瓣置换市场展望：历史（2019-2023年）与预测（2024-2031年）

第9章 拉丁美洲经导管主动脉瓣置换市场展望：历史（2019-2023年）与预测（2024-2031年）

第10章 中东和非洲经导管主动脉瓣置换市场展望：历史（2019-2023年）和预测（2024-2031年）

第11章 竞争态势

  • 2023年市占率分析
  • 市场结构
    • 依市场划分的竞争强度图
    • 竞争仪表板
  • 公司简介（详细资料 - 概述、财务状况、策略、近期发展）
    • Boston Scientific Corporation
    • Medtronic Plc
    • Abbott Laboratories
    • Anteris Technologies Ltd.
    • Coroneo Inc.
    • CryoLife Inc.
    • Edward Lifesciences Corporation
    • JenaValve Technology Inc.
    • LifeNet Health Inc.
    • LivaNova PLC
    • Thubrikar Aortic Valve Inc.

第12章 附录

  • 调查方法
  • 调查的先决条件
  • 首字母缩写词和缩写词
简介目录
Product Code: PMRREP34740

Persistence Market Research has recently published a comprehensive report on the global Transcatheter Aortic Valve Replacement (TAVR) Market, offering an in-depth analysis of key market dynamics such as drivers, opportunities, challenges, and trends. The report provides valuable insights into the structure and future prospects of the market.

Key Insights:

  • Transcatheter Aortic Valve Replacement Market Size (2024E): USD 5.64 Bn
  • Projected Market Value (2031F): USD 10.5 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 6.5%

Transcatheter Aortic Valve Replacement Market - Report Scope:

The TAVR market focuses on the transcatheter-based procedure for replacing damaged aortic valves, particularly for patients who are at high or intermediate risk during traditional open-heart surgeries. This market is expanding rapidly due to advancements in valve technology and minimally invasive techniques. The increased adoption of TAVR procedures is being witnessed in hospitals, specialized cardiac centers, and clinics worldwide, driven by the aging population and the rising prevalence of cardiovascular diseases.

Market Growth Drivers:

The global TAVR market is primarily driven by the expanding indications for TAVR procedures, particularly for low-risk patients. The development of flexible and advanced delivery systems has enabled smoother and safer implantation procedures. Continuous innovation in valve materials and enhancements in valve durability are further supporting market growth. Additionally, the increasing aging population and the high prevalence of aortic stenosis contribute to the growing demand for TAVR procedures.

Market Restraints:

While the TAVR market shows promising growth, several challenges impede its full potential. High costs of TAVR devices and procedures, coupled with the complex regulatory landscape, particularly in emerging markets, present significant barriers. Additionally, a lack of skilled professionals in certain regions to perform these highly specialized procedures limits broader market adoption. Concerns over long-term valve durability in low-risk patients also pose challenges to market expansion.

Market Opportunities:

The TAVR market offers significant growth opportunities, especially in emerging markets with ongoing healthcare modernization efforts. Increasing healthcare expenditure and improving access to advanced treatments in regions like Asia-Pacific are creating lucrative opportunities for market players. Additionally, growing awareness of minimally invasive treatments and the rising preference for non-surgical options among the elderly population are boosting demand for TAVR procedures.

Key Questions Answered in the Report:

  • What are the key factors driving the TAVR market globally?
  • How is the market expanding in different healthcare settings?
  • Which technological innovations are shaping the future of TAVR procedures?
  • Who are the leading players in the market, and what strategies are they adopting to stay competitive?
  • What are the emerging trends in the global TAVR market?

Competitive Intelligence and Business Strategy:

Leading players in the global TAVR market are investing in research and development (R&D) to innovate advanced valve systems and delivery platforms. Companies are focusing on strategic partnerships with hospitals and specialized cardiac centers to increase the adoption of TAVR procedures. Significant emphasis is placed on consumer education and regulatory approvals, which play a critical role in the competitive landscape.

Key Market Players

  • Boston Scientific Corporation
  • Medtronic Plc
  • Abbott Laboratories
  • Anteris Technologies Ltd.
  • Coroneo Inc.
  • CryoLife Inc.
  • Edward Lifesciences Corporation
  • JenaValve Technology Inc.
  • LifeNet Health Inc.
  • LivaNova PLC
  • Thubrikar Aortic Valve Inc.

Transcatheter Aortic Valve Replacement Market Segmentation

By Procedure

  • Transfemoral Implantation
  • Transapical Implantation
  • Transaortic Implantation

By Mechanism

  • Self-Expanding
  • Balloon-expandable

By End User

  • Hospital
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • The Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Transcatheter Aortic Valve Replacement Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Transcatheter Aortic Valve Replacement Adoption / Usage Analysis, By Region
  • 2.4. PESTLE Analysis
  • 2.5. Key Regulations by Region
  • 2.6. Porter Five Force's Analysis
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview

3. Price Trend Analysis, 2019-2031

  • 3.1. Key Highlights
  • 3.2. Key Factors Impacting Procedure Prices
  • 3.3. Prices By Procedure
  • 3.4. Regional Prices and Procedure Preferences

4. Global Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 4.1. Key Highlights
    • 4.1.1. Market Value (US$ in Bn) Projections
    • 4.1.2. Market Size and Y-o-Y Growth
    • 4.1.3. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size Analysis, 2019-2023
    • 4.2.2. Current Market Size Forecast, 2023-2031
  • 4.3. Global Transcatheter Aortic Valve Replacement Market Outlook: Procedure
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) and Volume (Units) and Analysis by Procedure, 2019-2023
    • 4.3.3. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
      • 4.3.3.1. Transfemoral Implantation
      • 4.3.3.2. Transapical Implantation
      • 4.3.3.3. Transaortic Implantation
  • 4.4. Market Attractiveness Analysis: Procedure
  • 4.5. Global Transcatheter Aortic Valve Replacement Market Outlook: Mechanism
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis by Mechanism, 2019-2023
    • 4.5.3. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
      • 4.5.3.1. Self-Expanding
      • 4.5.3.2. Balloon-Expandable
  • 4.6. Market Attractiveness Analysis: Mechanism
  • 4.7. Global Transcatheter Aortic Valve Replacement Market Outlook: End-use
    • 4.7.1. Introduction / Key Findings
    • 4.7.2. Historical Market Size (US$ Bn) Analysis by End-use, 2019-2023
    • 4.7.3. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
      • 4.7.3.1. Hospital
      • 4.7.3.2. Ambulatory Surgical Centers
      • 4.7.3.3. Others
  • 4.8. Market Attractiveness Analysis: End-use

5. Global Transcatheter Aortic Valve Replacement Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis by Region, 2019-2023
  • 5.3. Current Market Size (US$ Bn) Forecast by Region, 2024-2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
    • 6.2.1. By Country
    • 6.2.2. By Procedure
    • 6.2.3. By Mechanism
    • 6.2.4. By End-use
  • 6.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
    • 6.4.1. Transfemoral Implantation
    • 6.4.2. Transapical Implantation
    • 6.4.3. Transaortic Implantation
  • 6.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
    • 6.5.1. Self-Expanding
    • 6.5.2. Balloon-expandable
  • 6.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
    • 6.6.1. Hospital
    • 6.6.2. Ambulatory Surgical Centers
    • 6.6.3. Dental Clinics
  • 6.7. Market Attractiveness Analysis

7. Europe Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
    • 7.2.1. By Country
    • 7.2.2. By Procedure
    • 7.2.3. By Mechanism
    • 7.2.4. By End-use
  • 7.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
    • 7.3.1. Germany
    • 7.3.2. Italy
    • 7.3.3. France
    • 7.3.4. U.K.
    • 7.3.5. Turkey
    • 7.3.6. Russia
    • 7.3.7. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
    • 7.4.1. Transfemoral Implantation
    • 7.4.2. Transapical Implantation
    • 7.4.3. Transaortic Implantation
  • 7.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
    • 7.5.1. Self-Expanding
    • 7.5.2. Balloon-expandable
  • 7.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
    • 7.6.1. Hospital
    • 7.6.2. Ambulatory Surgical Centers
    • 7.6.3. Dental Clinics
  • 7.7. Market Attractiveness Analysis

8. Asia Pacific Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
    • 8.2.1. By Country
    • 8.2.2. By Procedure
    • 8.2.3. By Mechanism
    • 8.2.4. By End-use
  • 8.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
    • 8.3.4. India
    • 8.3.5. Southeast Asia
    • 8.3.6. Rest of Asia Pacific
  • 8.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
    • 8.4.1. Transfemoral Implantation
    • 8.4.2. Transapical Implantation
    • 8.4.3. Transaortic Implantation
  • 8.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
    • 8.5.1. Self-Expanding
    • 8.5.2. Balloon-expandable
  • 8.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
    • 8.6.1. Hospital
    • 8.6.2. Ambulatory Surgical Centers
    • 8.6.3. Dental Clinics
  • 8.7. Market Attractiveness Analysis

9. Latin America Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
    • 9.2.1. By Country
    • 9.2.2. By Procedure
    • 9.2.3. By Mechanism
    • 9.2.4. By End-use
  • 9.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Argentina
    • 9.3.4. Rest of Latin America
  • 9.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
    • 9.4.1. Transfemoral Implantation
    • 9.4.2. Transapical Implantation
    • 9.4.3. Transaortic Implantation
  • 9.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
    • 9.5.1. Self-Expanding
    • 9.5.2. Balloon-expandable
  • 9.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
    • 9.6.1. Hospital
    • 9.6.2. Ambulatory Surgical Centers
    • 9.6.3. Dental Clinics
  • 9.7. Market Attractiveness Analysis

10. Middle East & Africa Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
    • 10.2.1. By Country
    • 10.2.2. By Procedure
    • 10.2.3. By Mechanism
    • 10.2.4. By End-use
  • 10.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
    • 10.3.1. GCC Countries
    • 10.3.2. South Africa
    • 10.3.3. Egypt
    • 10.3.4. Nigeria
    • 10.3.5. Rest of Middle East and Africa
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
    • 10.4.1. Transfemoral Implantation
    • 10.4.2. Transapical Implantation
    • 10.4.3. Transaortic Implantation
  • 10.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
    • 10.5.1. Self-Expanding
    • 10.5.2. Balloon-expandable
  • 10.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
    • 10.6.1. Hospital
    • 10.6.2. Ambulatory Surgical Centers
    • 10.6.3. Dental Clinics
  • 10.7. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping by Market
    • 11.2.2. Competition Dashboard
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Boston Scientific Corporation
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Medtronic Plc
    • 11.3.3. Abbott Laboratories
    • 11.3.4. Anteris Technologies Ltd.
    • 11.3.5. Coroneo Inc.
    • 11.3.6. CryoLife Inc.
    • 11.3.7. Edward Lifesciences Corporation
    • 11.3.8. JenaValve Technology Inc.
    • 11.3.9. LifeNet Health Inc.
    • 11.3.10. LivaNova PLC
    • 11.3.11. Thubrikar Aortic Valve Inc.

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations